Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-03

Clinical Trial Update: Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ethoxysuximide and pentoxifylline for abdominal pain in irritable bowel syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)
  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tanta University | Conditions: IBS - Irritable Bowel Syndrome | Phase 3 | Status: RECRUITING